Cases & Deals

EluSys develops patent portfolio for antibody heteropolymers for treatment of cancer and infectious disease

Clients EluSys Therapeutics, Inc.

Jones Day managed the patent portfolio for EluSys Therapeutics, Inc. relating to antibody heteropolymers for treatment of cancer and infectious disease.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.